Literature DB >> 24457357

Long-term outcomes of Fine Needle Diathermy for established corneal neovascularisation.

S Trikha1, S Parikh, C Osmond, D F Anderson, P N Hossain.   

Abstract

BACKGROUND/AIMS: Corneal neovascularisation (CoNV) can lead to significant ocular comorbidity with reduction in vision and cosmesis. A number of techniques have been described to reduce CoNV, but these can be expensive. Our study aimed to determine the safety, efficacy and long-term outcomes of fine needle diathermy (FND) for CoNV.
METHODS: A 5-year retrospective study identified all cases of FND. Indications, intraoperative complications, and postoperative visual acuity, after treatment and retreatments, were documented, along with the procedure time. Evidence of regression and number of retreatments were identified.
RESULTS: 56 eyes from 52 patients underwent FND for CoNV. The main indications included herpes simplex keratitis (HSK) (53%, n=25) and microbial keratitis/peripheral ulcerative keratitis (13%, n=6). Pretreatment acuity was significantly correlated with extent of CoNV (p=0.044). One complication was noted during the procedure-an intrastromal and subconjunctival haemorrhage (rate 2%). 68.1% of patients demonstrated regression at first follow-up (mean 6.9 weeks), and 89.3% (n=42) showed regression with two or less treatments. Mean post-FND acuity was 0.72 (range -0.2-3.0) vs 0.82 (-0.2-3.0) preprocedure (p=0.08). VA improved in the HSK subgroup (p=0.012). Mean follow-up was 18.9 months (range 1-56 months).
CONCLUSIONS: In the largest case series reported, FND appears to be a safe and effective technique in the long term to induce regression of CoNV, with significant improvement in the VA of patients with HSK.

Entities:  

Keywords:  Cornea; Neovascularisation

Mesh:

Year:  2014        PMID: 24457357     DOI: 10.1136/bjophthalmol-2013-303729

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  8 in total

Review 1.  Current and emerging therapies for corneal neovascularization.

Authors:  Danial Roshandel; Medi Eslani; Alireza Baradaran-Rafii; Albert Y Cheung; Khaliq Kurji; Sayena Jabbehdari; Alejandra Maiz; Setareh Jalali; Ali R Djalilian; Edward J Holland
Journal:  Ocul Surf       Date:  2018-06-20       Impact factor: 5.033

2.  In Vivo Photoacoustic Imaging of Anterior Ocular Vasculature: A Random Sample Consensus Approach.

Authors:  Seungwan Jeon; Hyun Beom Song; Jaewoo Kim; Byung Joo Lee; Ravi Managuli; Jin Hyoung Kim; Jeong Hun Kim; Chulhong Kim
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

3.  Functional Staging of Corneal Neovascularization Using Fluorescein and Indocyanine Green Angiography.

Authors:  Christoph Palme; Vito Romano; Matthias Brunner; Riccardo Vinciguerra; Stephen B Kaye; Bernhard Steger
Journal:  Transl Vis Sci Technol       Date:  2018-10-01       Impact factor: 3.283

4.  Risk of Corneal Graft Rejection After High-risk Keratoplasty Following Fine-needle Vessel Coagulation of Corneal Neovascularization Combined With Bevacizumab: A Pilot Study.

Authors:  Deniz Hos; Viet Nhat Hung Le; Martin Hellmich; Sebastian Siebelmann; Sigrid Roters; Bjoern O Bachmann; Claus Cursiefen
Journal:  Transplant Direct       Date:  2019-04-25

Review 5.  Corneal neovascularization: updates on pathophysiology, investigations & management.

Authors:  Zuhair Sharif; Walid Sharif
Journal:  Rom J Ophthalmol       Date:  2019 Jan-Mar

6.  Supplemental Anti Vegf A-Therapy Prevents Rebound Neovascularisation After Fine Needle Diathermy Treatment to Regress Pathological Corneal (LYMPH)Angiogenesis.

Authors:  Viet Nhat Hung Le; Yanhong Hou; Felix Bock; Claus Cursiefen
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

7.  Fine Needle-Diathermy Regresses Pathological Corneal (Lymph)Angiogenesis and Promotes High-Risk Corneal Transplant Survival.

Authors:  Viet Nhat Hung Le; Ann-Charlott Schneider; Rebecca Scholz; Felix Bock; Claus Cursiefen
Journal:  Sci Rep       Date:  2018-04-09       Impact factor: 4.379

8.  VEGF TrapR1R2 Suspended in the Semifluorinated Alkane F6H8 Inhibits Inflammatory Corneal Hem- and Lymphangiogenesis.

Authors:  Viet Nhat Hung Le; Deniz Hos; Yanhong Hou; Madlen Witt; Mikhail Barkovskiy; Felix Bock; Claus Cursiefen
Journal:  Transl Vis Sci Technol       Date:  2020-10-14       Impact factor: 3.283

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.